Skip to main content
FinSpry Logo
FinSpry
FTH logo
FTH
(NASDAQ)
Faeth Therapeutics, Inc.
$39.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Faeth Therapeutics (FTH) Stock Price & Financial Analysis

Faeth Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$38.94 - $42.14
52-Week High$42.14
52-Week Low$7.45
Open$40.91
Volume292.08K
Average Volume (3M)299.27K
Market Cap51.87M
Shares Outstanding1.30M
Price to Book (P/B)0.27
EV/EBITDA0.53
Revenue (TTM)-4.85M
Net Income (TTM)-184.46M
Free Cash Flow (TTM)-24.11M
EPS (TTM)$-145.30
Return on Equity (ROE)-96.48%
Debt to Equity0.01
50-Day MA$30.18
200-Day MA$21.86
52-Week Change394.33%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Faeth Therapeutics

What is the current stock price for FTH?

As of the latest trading session, FTH stock trades at $39.20. The 52-week range is $7.45–$42.14, with a day range of $38.94–$42.14.

What is the P/E ratio for FTH?

The P/E ratio (Price-to-Earnings) for FTH is shown in the Key Statistics section. This valuation metric helps compare Faeth Therapeutics, Inc. to industry peers.

Does FTH pay dividends?

Faeth Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FTH?

Based on 4 analysts, the consensus for FTH is Buy.

What is the market cap of FTH?

Faeth Therapeutics's market capitalization is $50.8M, classifying it as a micro-cap company. Faeth Therapeutics operates in the Healthcare sector within the Biotechnology industry.